カテゴリー： LP Information, 世界, 医療/バイオ

世界のシアノコバラミン注射市場予測 2021年-2026年

【英語タイトル】Global Cyanocobalamin Injection Market Growth 2021-2026

LP Informationが出版した調査資料（LPI21MY9499）・商品コード：LPI21MY9499
・発行会社（調査会社）：LP Information
・発行日：2021年5月（※2024年版があります。お問い合わせください）
・ページ数：160
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥541,680見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥812,520見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,083,360見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
LPインフォメーション社の「シアノコバラミン注射の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、ビタミン、サプリメントなど、用途別には、病院、クリニック、その他などにセグメント区分してまとめました。シアノコバラミン注射のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。
・シアノコバラミン注射の世界市場概要（サマリー）
・シアノコバラミン注射の企業別販売量・売上
・シアノコバラミン注射の企業別市場シェア
・シアノコバラミン注射の世界市場規模 2016年-2021年：種類別（ビタミン、サプリメント）
・シアノコバラミン注射の世界市場規模 2016年-2021年：用途別（病院、クリニック、その他）
・シアノコバラミン注射の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど）
・シアノコバラミン注射のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）
・シアノコバラミン注射のヨーロッパ市場規模（ドイツ、フランス、イギリス、イタリア、ロシアなど）
・シアノコバラミン注射の中東・アフリカ市場（エジプト、南アフリカ、トルコ、GCC諸国など）
・シアノコバラミン注射市場の成長要因・課題・動向
・シアノコバラミン注射の世界市場予測 2021年-2026年
・シアノコバラミン注射の南北アメリカ市場予測（アメリカ、カナダ、メキシコなど）
・シアノコバラミン注射のアジア市場予測（日本、中国、韓国、インド、東南アジアなど）
・シアノコバラミン注射のヨーロッパ市場予測（ドイツ、フランス、イギリス、イタリア、ロシアなど）
・シアノコバラミン注射の中東・アフリカ市場予測（エジプト、南アフリカ、トルコ、GCC諸国など）
・シアノコバラミン注射の世界市場予測：種類別（ビタミン、サプリメント）
・シアノコバラミン注射の世界市場予測：用途別（病院、クリニック、その他）
・主要企業分析
【レポートの概要】

According to this latest study, the 2020 growth of Cyanocobalamin Injection will have significant change from previous year. By the most conservative estimates of global Cyanocobalamin Injection market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Cyanocobalamin Injection market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of Cyanocobalamin Injection market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Vitamins
Supplements

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Hospitals
Clinics
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Luitpold Pharmaceuticals
Luitpold Pharmaceuticals (Daiichi Sankyo)
Endo International
Bristol-Myers Squibb
Sanofi-Aventis
Jamieson
Teva (Actavis)
Merck
Mylan
Bayer HealthCare
Pfizer
ANGELINI
Biological E
CCEPCD
Huaxin Pharmaceutical

【レポートの目次】

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Cyanocobalamin Injection Consumption 2016-2026
2.1.2 Cyanocobalamin Injection Consumption CAGR by Region
2.2 Cyanocobalamin Injection Segment by Type
2.2.1 Vitamins
2.2.2 Supplements
2.3 Cyanocobalamin Injection Sales by Type
2.3.1 Global Cyanocobalamin Injection Sales Market Share by Type (2016-2021)
2.3.2 Global Cyanocobalamin Injection Revenue and Market Share by Type (2016-2021)
2.3.3 Global Cyanocobalamin Injection Sale Price by Type (2016-2021)
2.4 Cyanocobalamin Injection Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Others
2.5 Cyanocobalamin Injection Sales by Application
2.5.1 Global Cyanocobalamin Injection Sale Market Share by Application (2016-2021)
2.5.2 Global Cyanocobalamin Injection Revenue and Market Share by Application (2016-2021)
2.5.3 Global Cyanocobalamin Injection Sale Price by Application (2016-2021)

3 Global Cyanocobalamin Injection by Company
3.1 Global Cyanocobalamin Injection Sales Market Share by Company
3.1.1 Global Cyanocobalamin Injection Sales by Company (2019-2021)
3.1.2 Global Cyanocobalamin Injection Sales Market Share by Company (2019-2021)
3.2 Global Cyanocobalamin Injection Revenue Market Share by Company
3.2.1 Global Cyanocobalamin Injection Revenue by Company (2019-2021)
3.2.2 Global Cyanocobalamin Injection Revenue Market Share by Company (2019-2021)
3.3 Global Cyanocobalamin Injection Sale Price by Company
3.4 Global Manufacturers Cyanocobalamin Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Cyanocobalamin Injection Product Location Distribution
3.4.2 Players Cyanocobalamin Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Cyanocobalamin Injection by Region
4.1 Global Cyanocobalamin Injection by Region
4.1.1 Global Cyanocobalamin Injection Sales by Region
4.1.2 Global Cyanocobalamin Injection Revenue by Region
4.2 Americas Cyanocobalamin Injection Sales Growth
4.3 APAC Cyanocobalamin Injection Sales Growth
4.4 Europe Cyanocobalamin Injection Sales Growth
4.5 Middle East & Africa Cyanocobalamin Injection Sales Growth

5 Americas
5.1 Americas Cyanocobalamin Injection Sales by Country
5.1.1 Americas Cyanocobalamin Injection Sales by Country (2016-2021)
5.1.2 Americas Cyanocobalamin Injection Revenue by Country (2016-2021)
5.2 Americas Cyanocobalamin Injection Sales by Type
5.3 Americas Cyanocobalamin Injection Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Cyanocobalamin Injection Sales by Region
6.1.1 APAC Cyanocobalamin Injection Sales by Region (2016-2021)
6.1.2 APAC Cyanocobalamin Injection Revenue by Region (2016-2021)
6.2 APAC Cyanocobalamin Injection Sales by Type
6.3 APAC Cyanocobalamin Injection Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Cyanocobalamin Injection by Country
7.1.1 Europe Cyanocobalamin Injection Sales by Country (2016-2021)
7.1.2 Europe Cyanocobalamin Injection Revenue by Country (2016-2021)
7.2 Europe Cyanocobalamin Injection Sales by Type
7.3 Europe Cyanocobalamin Injection Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Cyanocobalamin Injection by Country
8.1.1 Middle East & Africa Cyanocobalamin Injection Sales by Country (2016-2021)
8.1.2 Middle East & Africa Cyanocobalamin Injection Revenue by Country (2016-2021)
8.2 Middle East & Africa Cyanocobalamin Injection Sales by Type
8.3 Middle East & Africa Cyanocobalamin Injection Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Cyanocobalamin Injection Distributors
10.3 Cyanocobalamin Injection Customer

11 Global Cyanocobalamin Injection Market Forecast
11.1 Global Cyanocobalamin Injection Forecast by Region
11.1.1 Global Cyanocobalamin Injection Forecast by Regions (2021-2026)
11.2.2 Global Cyanocobalamin Injection Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Countries
11.3 APAC Forecast by Region
11.4 Europe Forecast by Countries
11.5 Middle East & Africa Forecast by Countries
11.6 Global Cyanocobalamin Injection Forecast by Type
11.7 Global Cyanocobalamin Injection Forecast by Application

12 Key Players Analysis
12.1 Luitpold Pharmaceuticals
12.1.1 Luitpold Pharmaceuticals Luitpold Pharmaceuticals Company Information
12.1.2 Luitpold Pharmaceuticals Cyanocobalamin Injection Product Offered
12.1.3 Luitpold Pharmaceuticals Cyanocobalamin Injection Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Luitpold Pharmaceuticals Main Business Overview
12.1.5 Luitpold Pharmaceuticals Latest Developments
12.2 Luitpold Pharmaceuticals (Daiichi Sankyo)
12.2.1 Luitpold Pharmaceuticals (Daiichi Sankyo) Company Information
12.2.2 Luitpold Pharmaceuticals (Daiichi Sankyo) Cyanocobalamin Injection Product Offered
12.2.3 Luitpold Pharmaceuticals (Daiichi Sankyo) Cyanocobalamin Injection Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Luitpold Pharmaceuticals (Daiichi Sankyo) Main Business Overview
12.2.5 Luitpold Pharmaceuticals (Daiichi Sankyo) Latest Developments
12.3 Endo International
12.3.1 Endo International Company Information
12.3.2 Endo International Cyanocobalamin Injection Product Offered
12.3.3 Endo International Cyanocobalamin Injection Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Endo International Main Business Overview
12.3.5 Endo International Latest Developments
12.4 Bristol-Myers Squibb
12.4.1 Bristol-Myers Squibb Company Information
12.4.2 Bristol-Myers Squibb Cyanocobalamin Injection Product Offered
12.4.3 Bristol-Myers Squibb Cyanocobalamin Injection Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Bristol-Myers Squibb Main Business Overview
12.4.5 Bristol-Myers Squibb Latest Developments
12.5 Sanofi-Aventis
12.5.1 Sanofi-Aventis Company Information
12.5.2 Sanofi-Aventis Cyanocobalamin Injection Product Offered
12.5.3 Sanofi-Aventis Cyanocobalamin Injection Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Sanofi-Aventis Main Business Overview
12.5.5 Sanofi-Aventis Latest Developments
12.6 Jamieson
12.6.1 Jamieson Company Information
12.6.2 Jamieson Cyanocobalamin Injection Product Offered
12.6.3 Jamieson Cyanocobalamin Injection Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Jamieson Main Business Overview
12.6.5 Jamieson Latest Developments
12.7 Teva (Actavis)
12.7.1 Teva (Actavis) Company Information
12.7.2 Teva (Actavis) Cyanocobalamin Injection Product Offered
12.7.3 Teva (Actavis) Cyanocobalamin Injection Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Teva (Actavis) Main Business Overview
12.7.5 Teva (Actavis) Latest Developments
12.8 Merck
12.8.1 Merck Company Information
12.8.2 Merck Cyanocobalamin Injection Product Offered
12.8.3 Merck Cyanocobalamin Injection Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Merck Main Business Overview
12.8.5 Merck Latest Developments
12.9 Mylan
12.9.1 Mylan Company Information
12.9.2 Mylan Cyanocobalamin Injection Product Offered
12.9.3 Mylan Cyanocobalamin Injection Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Mylan Main Business Overview
12.9.5 Mylan Latest Developments
12.10 Bayer HealthCare
12.10.1 Bayer HealthCare Company Information
12.10.2 Bayer HealthCare Cyanocobalamin Injection Product Offered
12.10.3 Bayer HealthCare Cyanocobalamin Injection Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Bayer HealthCare Main Business Overview
12.10.5 Bayer HealthCare Latest Developments
12.11 Pfizer
12.11.1 Pfizer Company Information
12.11.2 Pfizer Cyanocobalamin Injection Product Offered
12.11.3 Pfizer Cyanocobalamin Injection Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 Pfizer Main Business Overview
12.11.5 Pfizer Latest Developments
12.12 ANGELINI
12.12.1 ANGELINI Company Information
12.12.2 ANGELINI Cyanocobalamin Injection Product Offered
12.12.3 ANGELINI Cyanocobalamin Injection Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 ANGELINI Main Business Overview
12.12.5 ANGELINI Latest Developments
12.13 Biological E
12.13.1 Biological E Company Information
12.13.2 Biological E Cyanocobalamin Injection Product Offered
12.13.3 Biological E Cyanocobalamin Injection Sales, Revenue, Price and Gross Margin (2019-2021)
12.13.4 Biological E Main Business Overview
12.13.5 Biological E Latest Developments
12.14 CCEPCD
12.14.1 CCEPCD Company Information
12.14.2 CCEPCD Cyanocobalamin Injection Product Offered
12.14.3 CCEPCD Cyanocobalamin Injection Sales, Revenue, Price and Gross Margin (2019-2021)
12.14.4 CCEPCD Main Business Overview
12.14.5 CCEPCD Latest Developments
12.15 Huaxin Pharmaceutical
12.15.1 Huaxin Pharmaceutical Company Information
12.15.2 Huaxin Pharmaceutical Cyanocobalamin Injection Product Offered
12.15.3 Huaxin Pharmaceutical Cyanocobalamin Injection Sales, Revenue, Price and Gross Margin (2019-2021)
12.15.4 Huaxin Pharmaceutical Main Business Overview
12.15.5 Huaxin Pharmaceutical Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Cyanocobalamin Injection Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Vitamins
Table 3. Major Players of Supplements
Table 4. Global Cyanocobalamin Injection Sales by Type (2016-2021) & (K Doses)
Table 5. Global Cyanocobalamin Injection Sales Market Share by Type (2016-2021)
Table 6. Global Cyanocobalamin Injection Revenue by Type (2016-2021) & ($ million)
Table 7. Global Cyanocobalamin Injection Revenue Market Share by Type (2016-2021)
Table 8. Global Cyanocobalamin Injection Sale Price by Type (2016-2021)
Table 9. Global Cyanocobalamin Injection Sales by Application (2016-2021) & (K Doses)
Table 10. Global Cyanocobalamin Injection Sales Market Share by Application (2016-2021)
Table 11. Global Cyanocobalamin Injection Value by Application (2016-2021)
Table 12. Global Cyanocobalamin Injection Revenue Market Share by Application (2016-2021)
Table 13. Global Cyanocobalamin Injection Sale Price by Application (2016-2021)
Table 14. Global Cyanocobalamin Injection Sales by Company (2019-2021) & (K Doses)
Table 15. Global Cyanocobalamin Injection Sales Market Share by Company (2019-2021)
Table 16. Global Cyanocobalamin Injection Revenue by Company (2019-2021) ($ Millions)
Table 17. Global Cyanocobalamin Injection Revenue Market Share by Company (2019-2021)
Table 18. Global Cyanocobalamin Injection Sale Price by Company (2019-2021)
Table 19. Key Manufacturers Cyanocobalamin Injection Producing Area Distribution and Sales Area
Table 20. Players Cyanocobalamin Injection Products Offered
Table 21. Cyanocobalamin Injection Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 22. New Products and Potential Entrants
Table 23. Mergers & Acquisitions, Expansion
Table 24. Global Cyanocobalamin Injection Sales by Region (2016-2021) (K Doses)
Table 25. Global Cyanocobalamin Injection Sales Market Share by Region (2016-2021)
Table 26. Global Cyanocobalamin Injection Revenue by Region (2016-2021) & ($ Millions)
Table 27. Global Cyanocobalamin Injection Revenue Market Share by Region (2016-2021)
Table 28. Americas Cyanocobalamin Injection Sales by Country (2016-2021) & (K Doses)
Table 29. Americas Cyanocobalamin Injection Sales Market Share by Country (2016-2021)
Table 30. Americas Cyanocobalamin Injection Revenue by Country (2016-2021) & ($ Millions)
Table 31. Americas Cyanocobalamin Injection Revenue Market Share by Country (2016-2021)
Table 32. Americas Cyanocobalamin Injection Sales by Type (2016-2021) & (K Doses)
Table 33. Americas Cyanocobalamin Injection Sales Market Share by Type (2016-2021)
Table 34. Americas Cyanocobalamin Injection Sales by Application (2016-2021) & (K Doses)
Table 35. Americas Cyanocobalamin Injection Sales Market Share by Application (2016-2021)
Table 36. APAC Cyanocobalamin Injection Sales by Region (2016-2021) & (K Doses)
Table 37. APAC Cyanocobalamin Injection Sales Market Share by Region (2016-2021)
Table 38. APAC Cyanocobalamin Injection Revenue by Region (2016-2021) & ($ Millions)
Table 39. APAC Cyanocobalamin Injection Revenue Market Share by Region (2016-2021)
Table 40. APAC Cyanocobalamin Injection Sales by Type (2016-2021) & (K Doses)
Table 41. APAC Cyanocobalamin Injection Sales Market Share by Type (2016-2021)
Table 42. APAC Cyanocobalamin Injection Sales by Application (2016-2021) & (K Doses)
Table 43. APAC Cyanocobalamin Injection Sales Market Share by Application (2016-2021)
Table 44. Europe Cyanocobalamin Injection Sales by Country (2016-2021) & (K Doses)
Table 45. Europe Cyanocobalamin Injection Sales Market Share by Country (2016-2021)
Table 46. Europe Cyanocobalamin Injection Revenue by Country (2016-2021) & ($ Millions)
Table 47. Europe Cyanocobalamin Injection Revenue Market Share by Country (2016-2021)
Table 48. Europe Cyanocobalamin Injection Sales by Type (2016-2021) & (K Doses)
Table 49. Europe Cyanocobalamin Injection Sales Market Share by Type (2016-2021)
Table 50. Europe Cyanocobalamin Injection Sales by Application (2016-2021) & (K Doses)
Table 51. Europe Cyanocobalamin Injection Sales Market Share by Application (2016-2021)
Table 52. Middle East & Africa Cyanocobalamin Injection Sales by Country (2016-2021) & (K Doses)
Table 53. Middle East & Africa Cyanocobalamin Injection Sales Market Share by Country (2016-2021)
Table 54. Middle East & Africa Cyanocobalamin Injection Revenue by Country (2016-2021) & ($ Millions)
Table 55. Middle East & Africa Cyanocobalamin Injection Revenue Market Share by Country (2016-2021)
Table 56. Middle East & Africa Cyanocobalamin Injection Sales by Type (2016-2021) & (K Doses)
Table 57. Middle East & Africa Cyanocobalamin Injection Sales Market Share by Type (2016-2021)
Table 58. Middle East & Africa Cyanocobalamin Injection Sales by Application (2016-2021) & (K Doses)
Table 59. Middle East & Africa Cyanocobalamin Injection Sales Market Share by Application (2016-2021)
Table 60. Global Cyanocobalamin Injection Sales Forecast by Type (2021-2026) & (K Doses)
Table 61. Global Cyanocobalamin Injection Sales Market Share Forecast by Type (2021-2026)
Table 62. Global Cyanocobalamin Injection Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 63. Global Cyanocobalamin Injection Revenue Market Share Forecast by Type (2021-2026)
Table 64. Global Cyanocobalamin Injection Sales Forecast by Application (2021-2026) & (K Doses)
Table 65. Global Cyanocobalamin Injection Sales Market Share Forecast by Application (2021-2026)
Table 66. Global Cyanocobalamin Injection Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 67. Global Cyanocobalamin Injection Revenue Market Share Forecast by Application (2021-2026)
Table 68. Luitpold Pharmaceuticals Basic Information, Cyanocobalamin Injection Manufacturing Base, Sales Area and Its Competitors
Table 69. Luitpold Pharmaceuticals Cyanocobalamin Injection Product Offered
Table 70. Luitpold Pharmaceuticals Cyanocobalamin Injection Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 71. Luitpold Pharmaceuticals Main Business
Table 72. Luitpold Pharmaceuticals Latest Developments
Table 73. Luitpold Pharmaceuticals (Daiichi Sankyo) Basic Information, Cyanocobalamin Injection Manufacturing Base, Sales Area and Its Competitors
Table 74. Luitpold Pharmaceuticals (Daiichi Sankyo) Cyanocobalamin Injection Product Offered
Table 75. Luitpold Pharmaceuticals (Daiichi Sankyo) Cyanocobalamin Injection Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 76. Luitpold Pharmaceuticals (Daiichi Sankyo) Main Business
Table 77. Luitpold Pharmaceuticals (Daiichi Sankyo) Latest Developments
Table 78. Endo International Basic Information, Cyanocobalamin Injection Manufacturing Base, Sales Area and Its Competitors
Table 79. Endo International Cyanocobalamin Injection Product Offered
Table 80. Endo International Cyanocobalamin Injection Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 81. Endo International Main Business
Table 82. Endo International Latest Developments
Table 83. Bristol-Myers Squibb Basic Information, Cyanocobalamin Injection Manufacturing Base, Sales Area and Its Competitors
Table 84. Bristol-Myers Squibb Cyanocobalamin Injection Product Offered
Table 85. Bristol-Myers Squibb Cyanocobalamin Injection Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 86. Bristol-Myers Squibb Main Business
Table 87. Bristol-Myers Squibb Latest Developments
Table 88. Sanofi-Aventis Basic Information, Cyanocobalamin Injection Manufacturing Base, Sales Area and Its Competitors
Table 89. Sanofi-Aventis Cyanocobalamin Injection Product Offered
Table 90. Sanofi-Aventis Cyanocobalamin Injection Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 91. Sanofi-Aventis Main Business
Table 92. Sanofi-Aventis Latest Developments
Table 93. Jamieson Basic Information, Cyanocobalamin Injection Manufacturing Base, Sales Area and Its Competitors
Table 94. Jamieson Cyanocobalamin Injection Product Offered
Table 95. Jamieson Cyanocobalamin Injection Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 96. Jamieson Main Business
Table 97. Jamieson Latest Developments
Table 98. Teva (Actavis) Basic Information, Cyanocobalamin Injection Manufacturing Base, Sales Area and Its Competitors
Table 99. Teva (Actavis) Cyanocobalamin Injection Product Offered
Table 100. Teva (Actavis) Cyanocobalamin Injection Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 101. Teva (Actavis) Main Business
Table 102. Teva (Actavis) Latest Developments
Table 103. Merck Basic Information, Cyanocobalamin Injection Manufacturing Base, Sales Area and Its Competitors
Table 104. Merck Cyanocobalamin Injection Product Offered
Table 105. Merck Cyanocobalamin Injection Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 106. Merck Main Business
Table 107. Merck Latest Developments
Table 108. Mylan Basic Information, Cyanocobalamin Injection Manufacturing Base, Sales Area and Its Competitors
Table 109. Mylan Cyanocobalamin Injection Product Offered
Table 110. Mylan Cyanocobalamin Injection Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 111. Mylan Main Business
Table 112. Mylan Latest Developments
Table 113. Bayer HealthCare Basic Information, Cyanocobalamin Injection Manufacturing Base, Sales Area and Its Competitors
Table 114. Bayer HealthCare Cyanocobalamin Injection Product Offered
Table 115. Bayer HealthCare Cyanocobalamin Injection Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 116. Bayer HealthCare Main Business
Table 117. Bayer HealthCare Latest Developments
Table 118. Pfizer Basic Information, Cyanocobalamin Injection Manufacturing Base, Sales Area and Its Competitors
Table 119. Pfizer Cyanocobalamin Injection Product Offered
Table 120. Pfizer Cyanocobalamin Injection Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 121. Pfizer Main Business
Table 122. Pfizer Latest Developments
Table 123. ANGELINI Basic Information, Cyanocobalamin Injection Manufacturing Base, Sales Area and Its Competitors
Table 124. ANGELINI Cyanocobalamin Injection Product Offered
Table 125. ANGELINI Cyanocobalamin Injection Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 126. ANGELINI Main Business
Table 127. ANGELINI Latest Developments
Table 128. Biological E Basic Information, Cyanocobalamin Injection Manufacturing Base, Sales Area and Its Competitors
Table 129. Biological E Cyanocobalamin Injection Product Offered
Table 130. Biological E Cyanocobalamin Injection Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 131. Biological E Main Business
Table 132. Biological E Latest Developments
Table 133. CCEPCD Basic Information, Cyanocobalamin Injection Manufacturing Base, Sales Area and Its Competitors
Table 134. CCEPCD Cyanocobalamin Injection Product Offered
Table 135. CCEPCD Cyanocobalamin Injection Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 136. CCEPCD Main Business
Table 137. CCEPCD Latest Developments
Table 138. Huaxin Pharmaceutical Basic Information, Cyanocobalamin Injection Manufacturing Base, Sales Area and Its Competitors
Table 139. Huaxin Pharmaceutical Cyanocobalamin Injection Product Offered
Table 140. Huaxin Pharmaceutical Cyanocobalamin Injection Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 141. Huaxin Pharmaceutical Main Business
Table 142. Huaxin Pharmaceutical Latest Developments
List of Figures
Figure 1. Picture of Cyanocobalamin Injection
Figure 2. Cyanocobalamin Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Cyanocobalamin Injection Sales Growth Rate 2016-2026 (K Doses)
Figure 7. Global Cyanocobalamin Injection Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Cyanocobalamin Injection Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Vitamins
Figure 10. Product Picture of Supplements
Figure 11. Global Cyanocobalamin Injection Sales Market Share by Type in 2020
Figure 12. Global Cyanocobalamin Injection Revenue Market Share by Type (2016-2021)
Figure 13. Cyanocobalamin Injection Consumed in Hospitals
Figure 14. Global Cyanocobalamin Injection Market: Hospitals (2016-2021) & (K Doses)
Figure 15. Cyanocobalamin Injection Consumed in Clinics
Figure 16. Global Cyanocobalamin Injection Market: Clinics (2016-2021) & (K Doses)
Figure 17. Cyanocobalamin Injection Consumed in Others
Figure 18. Global Cyanocobalamin Injection Market: Others (2016-2021) & (K Doses)
Figure 19. Global Cyanocobalamin Injection Sales Market Share by Application (2016-2021)
Figure 20. Global Cyanocobalamin Injection Revenue Market Share by Application in 2020
Figure 21. Global Cyanocobalamin Injection Revenue Market by Company in 2020 ($ Million)
Figure 22. Global Cyanocobalamin Injection Revenue Market Share by Company in 2020
Figure 23. Global Cyanocobalamin Injection Sales Market Share by Regions (2016-2021)
Figure 24. Global Cyanocobalamin Injection Revenue Market Share by Region in 2020
Figure 25. Americas Cyanocobalamin Injection Sales 2016-2021 (K Doses)
Figure 26. Americas Cyanocobalamin Injection Revenue 2016-2021 ($ Millions)
Figure 27. APAC Cyanocobalamin Injection Sales 2016-2021 (K Doses)
Figure 28. APAC Cyanocobalamin Injection Revenue 2016-2021 ($ Millions)
Figure 29. Europe Cyanocobalamin Injection Sales 2016-2021 (K Doses)
Figure 30. Europe Cyanocobalamin Injection Revenue 2016-2021 ($ Millions)
Figure 31. Middle East & Africa Cyanocobalamin Injection Sales 2016-2021 (K Doses)
Figure 32. Middle East & Africa Cyanocobalamin Injection Revenue 2016-2021 ($ Millions)
Figure 33. Americas Cyanocobalamin Injection Sales Market Share by Country in 2020
Figure 34. Americas Cyanocobalamin Injection Revenue Market Share by Country in 2020
Figure 35. Americas Cyanocobalamin Injection Sales Market Share by Type in 2020
Figure 36. Americas Cyanocobalamin Injection Sales Market Share by Application in 2020
Figure 37. United States Cyanocobalamin Injection Revenue Growth 2016-2021 ($ Millions)
Figure 38. Canada Cyanocobalamin Injection Revenue Growth 2016-2021 ($ Millions)
Figure 39. Mexico Cyanocobalamin Injection Revenue Growth 2016-2021 ($ Millions)
Figure 40. Brazil Cyanocobalamin Injection Revenue Growth 2016-2021 ($ Millions)
Figure 41. APAC Cyanocobalamin Injection Sales Market Share by Region in 2020
Figure 42. APAC Cyanocobalamin Injection Revenue Market Share by Regions in 2020
Figure 43. APAC Cyanocobalamin Injection Sales Market Share by Type in 2020
Figure 44. APAC Cyanocobalamin Injection Sales Market Share by Application in 2020
Figure 45. China Cyanocobalamin Injection Revenue Growth 2016-2021 ($ Millions)
Figure 46. Japan Cyanocobalamin Injection Revenue Growth 2016-2021 ($ Millions)
Figure 47. Korea Cyanocobalamin Injection Revenue Growth 2016-2021 ($ Millions)
Figure 48. Southeast Asia Cyanocobalamin Injection Revenue Growth 2016-2021 ($ Millions)
Figure 49. India Cyanocobalamin Injection Revenue Growth 2016-2021 ($ Millions)
Figure 50. Australia Cyanocobalamin Injection Revenue Growth 2016-2021 ($ Millions)
Figure 51. Europe Cyanocobalamin Injection Sales Market Share by Country in 2020
Figure 52. Europe Cyanocobalamin Injection Revenue Market Share by Country in 2020
Figure 53. Europe Cyanocobalamin Injection Sales Market Share by Type in 2020
Figure 54. Europe Cyanocobalamin Injection Sales Market Share by Application in 2020
Figure 55. Germany Cyanocobalamin Injection Revenue Growth 2016-2021 ($ Millions)
Figure 56. France Cyanocobalamin Injection Revenue Growth 2016-2021 ($ Millions)
Figure 57. UK Cyanocobalamin Injection Revenue Growth 2016-2021 ($ Millions)
Figure 58. Italy Cyanocobalamin Injection Revenue Growth 2016-2021 ($ Millions)
Figure 59. Russia Cyanocobalamin Injection Revenue Growth 2016-2021 ($ Millions)
Figure 60. Middle East & Africa Cyanocobalamin Injection Sales Market Share by Country in 2020
Figure 61. Middle East & Africa Cyanocobalamin Injection Revenue Market Share by Country in 2020
Figure 62. Middle East & Africa Cyanocobalamin Injection Sales Market Share by Type in 2020
Figure 63. Middle East & Africa Cyanocobalamin Injection Sales Market Share by Application in 2020
Figure 64. Egypt Cyanocobalamin Injection Revenue Growth 2016-2021 ($ Millions)
Figure 65. South Africa Cyanocobalamin Injection Revenue Growth 2016-2021 ($ Millions)
Figure 66. Israel Cyanocobalamin Injection Revenue Growth 2016-2021 ($ Millions)
Figure 67. Turkey Cyanocobalamin Injection Revenue Growth 2016-2021 ($ Millions)
Figure 68. GCC Country Cyanocobalamin Injection Revenue Growth 2016-2021 ($ Millions)
Figure 69. Channels of Distribution
Figure 70. Distributors Profiles


★調査レポート[世界のシアノコバラミン注射市場予測 2021年-2026年] (コード：LPI21MY9499)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のシアノコバラミン注射市場予測 2021年-2026年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のシアノコバラミンスプレー市場予測 2021年-2026年
    LPI21MY9500 / LP Information / 2021年5月 / LPインフォメーション社の「シアノコバラミンスプレーの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、ビタミン、サプリメントなど、用途別には、病院、クリニック、その他などにセグメント区分してまとめました。シアノコバラミンスプレーのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・シアノコバラミンスプレーの世界市場概要（サマリー） ・シアノコバラミンスプレーの企業別販売量・売上 ・シアノコバラミンスプレーの企業別市場シェア ・シアノコバラミンスプレーの世界市場規模 2016年-2021年：種類別（ビタミン、サプリメント） ・シアノコバラミンスプレーの世界市場規模 2016年-2021年：用途別（病院、クリニック、その他） ・シアノコバラミンスプレーの南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・シアノコバラミンスプレーのアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Cyanocobalamin Spray will have significant change from previous year. By the most conservative estimates of global Cyanocobalamin Spray market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Cyanocobalamin Spray market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Cyanocobalamin Spray market by product type, application, key manufacturers and...
  • 世界のブドウ糖注射液市場予測 2021年-2026年
    LPI21MY9540 / LP Information / 2021年5月 / LPインフォメーション社の「ブドウ糖注射液の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、5％注射液、10％注射液、50％注射液、70％注射液、その他など、用途別には、スポーツ、応急処置、栄養療法、その他などにセグメント区分してまとめました。ブドウ糖注射液のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・ブドウ糖注射液の世界市場概要（サマリー） ・ブドウ糖注射液の企業別販売量・売上 ・ブドウ糖注射液の企業別市場シェア ・ブドウ糖注射液の世界市場規模 2016年-2021年：種類別（5％注射液、10％注射液、50％注射液、70％注射液、その他） ・ブドウ糖注射液の世界市場規模 2016年-2021年：用途別（スポーツ、応急処置、栄養療法、その他） ・ブドウ糖注射液の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・ブドウ糖注射液のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Glucose Injection will have significant change from previous year. By the most conservative estimates of global Glucose Injection market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Glucose Injection market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Glucose Injection market by product type, application, key manufacturers and...
  • 世界の注射用オマリズマブ市場予測 2021年-2026年
    LPI21MY9606 / LP Information / 2021年5月 / LPインフォメーション社の「注射用オマリズマブの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、注射用皮下粉末、皮下液（150mg / mL）、皮下液（75mg / 0.5mL）など、用途別には、病院、診療所などにセグメント区分してまとめました。注射用オマリズマブのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・注射用オマリズマブの世界市場概要（サマリー） ・注射用オマリズマブの企業別販売量・売上 ・注射用オマリズマブの企業別市場シェア ・注射用オマリズマブの世界市場規模 2016年-2021年：種類別（注射用皮下粉末、皮下液（150mg...According to this latest study, the 2020 growth of Omalizumab for Injection will have significant change from previous year. By the most conservative estimates of global Omalizumab for Injection market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Omalizumab for Injection market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Omalizumab for Injection market by product type,...
  • 世界のセフトリアキソン注射市場予測 2021年-2026年
    LPI21MY9472 / LP Information / 2021年5月 / LPインフォメーション社の「セフトリアキソン注射の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、単回注射、複方注射など、用途別には、病院、クリニックなどにセグメント区分してまとめました。セフトリアキソン注射のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・セフトリアキソン注射の世界市場概要（サマリー） ・セフトリアキソン注射の企業別販売量・売上 ・セフトリアキソン注射の企業別市場シェア ・セフトリアキソン注射の世界市場規模 2016年-2021年：種類別（単回注射、複方注射） ・セフトリアキソン注射の世界市場規模 2016年-2021年：用途別（病院、クリニック） ・セフトリアキソン注射の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・セフトリアキソン注射のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2021 growth of Ceftriaxone Injection will have significant change from previous year. By the most conservative estimates of global Ceftriaxone Injection market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Ceftriaxone Injection market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of Ceftriaxone Injection market by product type, application, key manufacturers and...
  • 世界のピペラシリン＆タゾバクタム注射市場予測 2021年-2026年
    LPI21MY9623 / LP Information / 2021年5月 / LPインフォメーション社の「ピペラシリン＆タゾバクタム注射の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、ピペラシリン注射、タゾバクタム注射など、用途別には、病院、診療所などにセグメント区分してまとめました。ピペラシリン＆タゾバクタム注射のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・ピペラシリン＆タゾバクタム注射の世界市場概要（サマリー） ・ピペラシリン＆タゾバクタム注射の企業別販売量・売上 ・ピペラシリン＆タゾバクタム注射の企業別市場シェア ・ピペラシリン＆タゾバクタム注射の世界市場規模 2016年-2021年：種類別（ピペラシリン注射、タゾバクタム注射） ・ピペラシリン＆タゾバクタム注射の世界市場規模 2016年-2021年：用途別（病院、診療所） ・ピペラシリン＆タゾバクタム注射の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・ピペラシリン＆タゾバクタム注射のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2021 growth of Piperacillin and tazobactam Injection will have significant change from previous year. By the most conservative estimates of global Piperacillin and tazobactam Injection market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Piperacillin and tazobactam Injection market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of Piperacillin and tazobactam Injection...
  • 世界の注射用エソメプラゾールナトリウム市場予測 2021年-2026年
    LPI21MY9523 / LP Information / 2021年5月 / LPインフォメーション社の「注射用エソメプラゾールナトリウムの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、40mg、20mgなど、用途別には、逆流性食道炎、胃潰瘍、急性胃潰瘍、十二指腸潰瘍出血などにセグメント区分してまとめました。注射用エソメプラゾールナトリウムのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・注射用エソメプラゾールナトリウムの世界市場概要（サマリー） ・注射用エソメプラゾールナトリウムの企業別販売量・売上 ・注射用エソメプラゾールナトリウムの企業別市場シェア ・注射用エソメプラゾールナトリウムの世界市場規模 2016年-2021年：種類別（40mg、20mg） ・注射用エソメプラゾールナトリウムの世界市場規模 2016年-2021年：用途別（逆流性食道炎、胃潰瘍、急性胃潰瘍、十二指腸潰瘍出血） ・注射用エソメプラゾールナトリウムの南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・注射用エソメプラゾールナトリウムのアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2021 growth of Eseomeprazole Sodium for Injection will have significant change from previous year. By the most conservative estimates of global Eseomeprazole Sodium for Injection market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Eseomeprazole Sodium for Injection market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of Eseomeprazole Sodium for Injection...
  • 世界の注射用エルタペネム市場予測 2021年-2026年
    LPI21MY1305 / LP Information / 2021年5月 / LPインフォメーション社の「注射用エルタペネムの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、純度> 98％、純度> 99％など、用途別には、静脈注射、筋肉内注射などにセグメント区分してまとめました。注射用エルタペネムのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・注射用エルタペネムの世界市場概要（サマリー） ・注射用エルタペネムの企業別販売量・売上 ・注射用エルタペネムの企業別市場シェア ・注射用エルタペネムの世界市場規模 2016年-2021年：種類別（純度> 98％、純度> 99％）...According to this latest study, the 2021 growth of Ertapenem for Injection will have significant change from previous year. By the most conservative estimates of global Ertapenem for Injection market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Ertapenem for Injection market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of Ertapenem for Injection market by product type,...
  • 世界の注射用滅菌水（SWFI）市場予測 2021年-2026年
    LPI21MY9658 / LP Information / 2021年5月 / LPインフォメーション社の「注射用滅菌水（SWFI）の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、バイアル、ガラス瓶、プレフィルドシリンジなど、用途別には、病院、クリニック、その他などにセグメント区分してまとめました。注射用滅菌水（SWFI）のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・注射用滅菌水（SWFI）の世界市場概要（サマリー） ・注射用滅菌水（SWFI）の企業別販売量・売上 ・注射用滅菌水（SWFI）の企業別市場シェア ・注射用滅菌水（SWFI）の世界市場規模 2016年-2021年：種類別（バイアル、ガラス瓶、プレフィルドシリンジ） ・注射用滅菌水（SWFI）の世界市場規模 2016年-2021年：用途別（病院、クリニック、その他） ・注射用滅菌水（SWFI）の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・注射用滅菌水（SWFI）のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2021 growth of Sterile Water for Injection (SWFI) will have significant change from previous year. By the most conservative estimates of global Sterile Water for Injection (SWFI) market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Sterile Water for Injection (SWFI) market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of Sterile...
  • 世界の軽自動車用燃料噴射市場予測 2021年-2026年
    LPI21MY0397 / LP Information / 2021年5月 / LPインフォメーション社の「軽自動車用燃料噴射の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、ガソリン直噴、ポート燃料など、用途別には、SUV、車、バイクなどにセグメント区分してまとめました。軽自動車用燃料噴射のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・軽自動車用燃料噴射の世界市場概要（サマリー） ・軽自動車用燃料噴射の企業別販売量・売上 ・軽自動車用燃料噴射の企業別市場シェア ・軽自動車用燃料噴射の世界市場規模 2016年-2021年：種類別（ガソリン直噴、ポート燃料） ・軽自動車用燃料噴射の世界市場規模 2016年-2021年：用途別（SUV、車、バイク） ・軽自動車用燃料噴射の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・軽自動車用燃料噴射のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Light Vehicle Fuel Injection will have significant change from previous year. By the most conservative estimates of global Light Vehicle Fuel Injection market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Light Vehicle Fuel Injection market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Light Vehicle Fuel Injection...
  • 世界の射出成形金型市場予測 2021年-2026年
    LPI21MY8063 / LP Information / 2021年5月 / LPインフォメーション社の「射出成形金型の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、2プレート射出成形金型、3プレート射出成形金型、スタック射出成形金型など、用途別には、自動車、家電、包装、電気・電子、医療、その他などにセグメント区分してまとめました。射出成形金型のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・射出成形金型の世界市場概要（サマリー） ・射出成形金型の企業別販売量・売上 ・射出成形金型の企業別市場シェア ・射出成形金型の世界市場規模 2016年-2021年：種類別（2プレート射出成形金型、3プレート射出成形金型、スタック射出成形金型） ・射出成形金型の世界市場規模 2016年-2021年：用途別（自動車、家電、包装、電気・電子、医療、その他） ・射出成形金型の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・射出成形金型のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2021 growth of Injection Mould will have significant change from previous year. By the most conservative estimates of global Injection Mould market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Injection Mould market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of Injection Mould market by product type, application, key manufacturers and...

    • ◆H&Iグローバルリサーチのお客様（例）◆